Deal of the Day — limited-time pharmacy picks!
Abirakast 250mg Tablet

Abirakast 250mg Tablet

Prescription requiredRx Required

Salt Composition: Abiraterone Acetate

Expiry Date: 01/2028

Special offer

Buy at $114.26

$114.26

Inclusive of all taxes

▼

120 Tablets

About The Product

Prostate Cancer

Abirakast 250mg Tablet belongs to the category of anti-androgens. This medicine used in the treatment of prostate cancer. It has an active ingredient Abiraterone Acetate which works by blocking the production of testosterone and other hormones that are responsible for the growth and spread of cancer cells from the prostate gland to other parts of the body. It is available with a fixed strength of 250 mg as tablets for oral administration only.

Uses

Prostate Cancer

Side Effects

  • Like any other anticancer medicine, Abirakast 250mg Tablet also shows some side effects, which vary from one person to another according to various health factors.
  • Most of them are mild, and some are serious enough to need immediate medical attention.
  • Some common side effects include: Diarrhea High blood pressure Cough Joint swelling Nausea Hot flashes Headache Increased glucose level in the blood Edema (swelling)
  • Vomiting Decreased potassium level in the blood Fatigue Anemia (low number of red blood cells)
  • Urinary tract infection Seek medical attention in case of any unusual or severe side effects immediately.

How To Use

  • Take Abirakast 250mg Tablet in the dosage and duration exactly as prescribed by the doctor.
  • The medicine should be taken orally on an empty stomach or can be consumed one hour before or two hours after a meal.
  • In case of an overdose, contact your doctor immediately.

How It Works

Abirakast 250mg Tablet is an anticancer medicine prescribed to treat prostate cancer. It works by blocking the action of CYP17 enzyme to stop the production of male hormones that are responsible for the prostate cancer.

In this way it slow down or stop the uncontrolled growth of cancer cells effectively.

Safety Advice

Alcohol
The interaction of alcohol with this drug is still unknown. It is advisable not to consume alcohol while taking Abirakast 250mg Tablet.
Pregnancy
Do not take Abirakast 250mg Tablet during pregnancy, as it is a highly unsafe medicine for the fetus. Also, this medicine is especially designed to treat male-related cancers.
Breast Feeding
Abirakast 250mg Tablet is unsafe to use during breastfeeding as it may cause toxicity to the baby. Also, this medicine is especially designed to treat male-related cancers.
Driving
Abirakast 250mg Tablet may cause side effects such as dizziness or lack of concentration, which could affect your ability to drive. So it's better to avoid driving or operating heavy machinery.
Kidney
Consumption of Abirakast 250mg Tablet should be avoided without informing the doctor if you have any kidney-related issues.
Liver
Consumption of Abirakast 250mg Tablet should be avoided without informing the doctor if you have any liver-related issues.

FAQs

Abirakast 250mg Tablet is an anticancer drug which work by managing the symptom & slowing down or controling the growth of cancer cells in the case of prostate cancer.

However this medicine can't cure prostate cancer completely.

Reference

1.Flaig, T. W., Plets, M., Hussain, M.

H., Agarwal, N., Mitsiades, N., Deshpande, H. A., ... & Thompson, I.

M. (2017).

Abiraterone acetate for metastatic prostate cancer in patients with suboptimal biochemical response to hormone induction. JAMA oncology, 3(11), e170231-e170231.

2.Chi, K. N., Spratlin, J., Kollmannsberger, C., North, S., Pankras, C., Gonzalez, M., ... & Tran, N.

P. (2015).

Food effects on abiraterone pharmacokinetics in healthy subjects and patients with metastatic castration‐resistant prostate cancer. The Journal of Clinical Pharmacology, 55(12), 1406-1414.

3.Shah, S., & Ryan, C. J.

(2009). Abiraterone acetate.

Drugs of the Future, 34(11). 4.Gonçalves, B.

F., de Campos, S. G.

P., Fávaro, W. J., Brandt, J.

Z., Pinho, C. F., Justulin, L.

A., ... & Scarano, W. R.

(2018). Combinatorial effect of abiraterone acetate and NVP-BEZ235 on prostate tumor progression in rats.

Hormones and Cancer, 9(3), 175-187. 5.

Taheri, A., Almasri, R., Wignall, A., Schultz, H. B., Elz, A.

S., Ariaee, A., ... & Prestidge, C. A.

(2024). Enhancing the pharmacokinetics of abiraterone acetate through lipid-based formulations: addressing solubility and food effect challenges.

Drug Delivery and Translational Research, 1-13.

i
Trust & safety

Medical Disclaimer

Accurate, reviewed information to support informed healthcare decisions

For informational purposes only
Not a substitute for professional medical advice
Consult your doctor for diagnosis and treatment

Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.

The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.

This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.

Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.

Always follow advice from your doctor, pharmacist, or other licensed healthcare professional before starting, stopping, or changing any medicine or treatment.
Read full medical disclaimer in Terms & Conditions
Magicine PharmacopyCopyright 2026